Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)

Solid Biosciences (SLDB) has 3 years of Restructuring Costs data on file, last reported at -$63000.0 in Q2 2023.

• For the quarter ending Q2 2023, Restructuring Costs fell 104.14% year-over-year to -$63000.0; the trailing twelve-month figure through Dec 2023 stood at $5.6 million (down 22.05% YoY), and the FY2023 full-year result was -$63000.0, down 100.88% from the prior year.
• Restructuring Costs slipped to -$63000.0 in Q2 2023, from $5.7 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $5.7 million in Q4 2022 to a low of -$63000.0 in Q2 2023.
• A 3-year average of $2.3 million and a median of $1.7 million in 2020 frame the typical range for Restructuring Costs.
• Peak annual rise in Restructuring Costs reached 104.14% in 2023, while the deepest fall reached 104.14% in 2023.
• Tracing SLDB's Restructuring Costs over 3 years: stood at $1.9 million in 2020, then soared by 191.05% to $5.7 million in 2022, then plunged by 101.11% to -$63000.0 in 2023.
• Business Quant data shows SLDB's Restructuring Costs at -$63000.0 in Q2 2023, $5.7 million in Q4 2022, and $1.5 million in Q2 2022.